294 related articles for article (PubMed ID: 26118895)
1. Molecular profiling of gliomas: potential therapeutic implications.
Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
[TBL] [Abstract][Full Text] [Related]
2. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
3. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic gliomas in adults: an update.
Izquierdo C; Joubert B; Ducray F
Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
[TBL] [Abstract][Full Text] [Related]
5. Predictive biomarkers in adult gliomas: the present and the future.
Thomas L; Di Stefano AL; Ducray F
Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583
[TBL] [Abstract][Full Text] [Related]
6. Treatment of anaplastic glioma.
Wick W; Wiestler B; Platten M
Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
[TBL] [Abstract][Full Text] [Related]
7. [Personalized therapy for gliomas].
Wick W; Hau P
Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
[TBL] [Abstract][Full Text] [Related]
8. [Management of gliomas].
Lévy S; Chapet S; Mazeron JJ
Cancer Radiother; 2014 Oct; 18(5-6):461-7. PubMed ID: 25201633
[TBL] [Abstract][Full Text] [Related]
9. Glioma biology and molecular markers.
Cohen AL; Colman H
Cancer Treat Res; 2015; 163():15-30. PubMed ID: 25468223
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic and predictive factors for gliomas in adults].
Frenel JS; Botti M; Loussouarn D; Campone M
Bull Cancer; 2009 Apr; 96(4):357-67. PubMed ID: 19357011
[TBL] [Abstract][Full Text] [Related]
11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
14. Management of diffusely infiltrating glioma in the elderly.
Wirsching HG; Happold C; Roth P; Weller M
Curr Opin Oncol; 2015 Nov; 27(6):502-9. PubMed ID: 26397765
[TBL] [Abstract][Full Text] [Related]
15. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Grant R; Kolb L; Moliterno J
CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
[TBL] [Abstract][Full Text] [Related]
16. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic glioma: current treatment and management.
Le Rhun E; Taillibert S; Chamberlain MC
Expert Rev Neurother; 2015 Jun; 15(6):601-20. PubMed ID: 25936680
[TBL] [Abstract][Full Text] [Related]
18. Glioma Subclassifications and Their Clinical Significance.
Chen R; Smith-Cohn M; Cohen AL; Colman H
Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
[TBL] [Abstract][Full Text] [Related]
19. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling.
Soffietti R; Franchino F; Magistrello M; Pellerino A; Rudà R
Prog Neurol Surg; 2018; 31():168-179. PubMed ID: 29393185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]